Review
Published on 08 Jul 2022
Triggering Receptors Expressed on Myeloid Cells 1 : Our New Partner in Human Oncology?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.927440
- 3,358 views
- 8 citations
Type at least 3 characters
1,009 articles
Articles
Original Research
Published on 07 Jul 2022
Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.925743
- 10,849 views
- 20 citations
Review
Published on 07 Jul 2022
Nanotech Probes: A Revolution in Cancer Diagnosis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.933125
- 2,632 views
- 5 citations
Original Research
Published on 06 Jul 2022
Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.938052
- 4,389 views
- 22 citations
Review
Published on 06 Jul 2022
Research Progress of Photothermal Nanomaterials in Multimodal Tumor Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.939365
- 4,746 views
- 20 citations
Original Research
Published on 04 Jul 2022
Nanozyme Hydrogels for Self-Augmented Sonodynamic/Photothermal Combination Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.888855
- 3,469 views
- 15 citations
Original Research
Published on 01 Jul 2022
Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.929996
- 3,352 views
- 4 citations
Case Report
Published on 01 Jul 2022
Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1)
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.862600
- 9,668 views
- 6 citations
Original Research
Published on 30 Jun 2022
Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT/β-Catenin Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.732860
- 3,818 views
- 16 citations
Original Research
Published on 30 Jun 2022
Injectable Hydrogel System for Camptothecin Initiated Nanocatalytic Tumor Therapy With High Performance
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.904960
- 1,916 views
- 3 citations
Original Research
Published on 30 Jun 2022
Cu-Hemin Nanosheets and Indocyanine Green Co-Loaded Hydrogel for Photothermal Therapy and Amplified Photodynamic Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.918416
- 3,124 views
- 6 citations
Case Report
Published on 29 Jun 2022
Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.843741
- 3,557 views
- 4 citations
Review
Published on 28 Jun 2022
Nanoparticle-Based Combination Therapy for Melanoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.928797
- 2,702 views
- 10 citations
Review
Published on 27 Jun 2022
Research Progress of DUB Enzyme in Hepatocellular Carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.920287
- 7,316 views
- 12 citations
Correction
Published on 27 Jun 2022
Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.916983
- 1,094 views
- 1 citation
Review
Published on 24 Jun 2022
Drug Repurposing by Tumor Tissue Editing
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.900985
- 3,038 views
- 8 citations